Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0851
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Inhibition of STAT3 augments antitumor efficacy of anti-CTLA-4 treatment against prostate cancer ; day:31 ; month:3 ; year:2021 ; pages:1-12
Cancer immunology immunotherapy ; (31.3.2021), 1-12
- Urheber
-
Witt, Kristina
Evans-Axelsson, Susan
Lundqvist, Andreas
Johansson, Martin
Bjartell, Anders
Hellsten, Rebecka
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00262-021-02915-6
- URN
-
urn:nbn:de:101:1-2021051618471366694029
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Witt, Kristina
- Evans-Axelsson, Susan
- Lundqvist, Andreas
- Johansson, Martin
- Bjartell, Anders
- Hellsten, Rebecka
- SpringerLink (Online service)
Ähnliche Objekte (12)
Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway
Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma
Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4
HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway
Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma
Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4
HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy
Indoleamine 2,3-dioxygenase is a critical resistance mechanism in anti-tumor T cell immunotherapy targeting CTLA-4
Anti-tumor and anti-angiogenic effects of Fucoidan on prostate cancer: possible JAK-STAT3 pathway
Fc-independent functions of anti-CTLA-4 antibodies contribute to anti-tumor efficacy
Ipilimumab augments antitumor activity of bispecific antibody-armed T cells
Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer
Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma
Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4
HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
Artesunate induces melanoma cell ferroptosis and augments antitumor immunity through targeting Ido1
Lactate increases stemness of CD8 + T cells to augment anti-tumor immunity
As1411-modified liposomes to enhance drug utilization and augment the anti-tumor efficacy